A Agilent Technologies Inc.

Agilent Presents Thought Leader Award to Dr. Stéphane Bayen

(NYSE: A) today announced that has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and Agricultural Chemistry at in Montreal, Quebec, Canada.

This press release features multimedia. View the full release here:

Dr. Stéphane Bayen, Associate Professor, Department of Food Science and Agricultural Chemistry, McGill University (Photo: Business Wire)

Dr. Stéphane Bayen, Associate Professor, Department of Food Science and Agricultural Chemistry, McGill University (Photo: Business Wire)

The award will support Dr. Bayen’s research contributions to analytical techniques and the development of reliable and robust workflows to identify honey authenticity using non-targeted chemical fingerprinting strategies.

Regarded as the next-generation surveillance approach for chemicals in food, non-targeted analysis using high-resolution mass spectrometry coupled with innovative software enables the rapid characterization of thousands of chemicals in complex food matrices such as honey.

“Honey is one of the top adulterated foods in the world,” said Mary McBride, associate vice president, Applied Markets and Regulations, Laboratory Solutions Marketing at Agilent, and executive sponsor of the award. “This award will help create routine and reliable non-targeted fingerprinting methods to ensure not only the authenticity of honey but its safety for consumers.”

“High-resolution mass spectrometry allows us to map food components in an unprecedented fashion,” said Dr. Bayen. “This approach will revolutionize the way we manage and regulate food quality, food safety, and food authenticity.”

Food authenticity testing utilizing chemical fingerprinting strategies is emerging as a more effective approach to track food fraud, and chemical fingerprints are virtually impossible to imitate due to their complexity.

The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space. To learn more, visit the web site.

About Agilent Technologies

Agilent is a leader in life sciences, diagnostics, and applied chemical markets, delivering innovative technology solutions that provide trusted answers to researchers’ most challenging scientific questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on , , and .

EN
14/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

 PRESS RELEASE

Agilent Receives Scientists' Choice Awards for Sustainability

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability. The award for Sustainable Supplier of the Year, recognizes Agilent’s demonstrated commitment to environmental responsibility and sustainability. The award acknowledges efforts in minimizing environmental impact through thoughtfully designed products, promoting eco-friendly practices, and actively contributing to ...

 PRESS RELEASE

Agilent Receives European IVDR Class C Certification for GenetiSure Dx...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that its has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the EU. In vitro diagnostic devices, which include pregnancy tests, COVID-19 tests, urine test strips, and more, are estimated to play a part in 70% of all diagnostic decisions.1 The EU has introduced the IVDR regulatory framework to e...

 PRESS RELEASE

Agilent Brings Great Science to Life at Analytica 2024

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany. Visit Agilent at Hall A2, Booth 201, to learn about recently introduced products and solutions enabling key workflows that are revolutionizing laboratories across industries including pharma and biopharma, food and environment...

 PRESS RELEASE

Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the . At the meeting, which will take place from April 5 to 10, 2024, in San Diego, CA, Agilent will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions. Featured products and solutions that play a crucial role in advancing cancer research and diagnostics, will include: Agilent NovoCyte Opteon Spectral Flow Cytometer - The Agilent NovoCyte Opteon Spectral Flow Cytometer, is an advanced solution in spectral flow ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch